Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 03/08/19981 min de lecture
Oral Dosage Form New Animal Drugs; Milbemycin Oxime Tablets
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Novartis Animal Health US, Inc. The supplemental NADA provides for use of a lower dose of milbemycin oxime in treating dogs and puppies for the prevention of heartworm disease.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →